PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 11 days 12 hours 51 minutes
Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them
Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them
The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal
The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes
A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes
Novel Approaches to Personalized Patient Care in Still's Disease
"Novel Approaches to Personalized Patient Care in Still's Disease"
Hepatitis C in the Clinic: Case-Based Approaches to Identify and Manage Patients With HCV
Hepatitis C in the Clinic: Case-Based Approaches to Identify and Manage Patients With HCV
Improving Outcomes in Patients With Major Depressive Disorder (MDD) Experiencing Anxiety Symptoms
Improving Outcomes in Patients With Major Depressive Disorder (MDD) Experiencing Anxiety Symptoms
Living With Multidrug-Resistant HIV: What Clinicians Need to Know
Living With Multidrug-Resistant HIV: What Clinicians Need to Know
The Holistic Care of Patients with T2DM: Going Beyond HbA1c
The Holistic Care of Patients with T2DM: Going Beyond HbA1c
Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action
Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action